STAAR Surgical Appoints Scott Barnes, MD, as New CMO

October 6, 2017: By Jon Swedien

STAAR Surgical logoSTAAR Surgical has appointed Scott D. Barnes, MD, to be its chief medical officer, a newly created position, the Monrovia, California, company announced Oct. 2.

Barnes will report to Caren Mason, STAAR’s president and CEO.

He will also serve on the executive management team and provide strategic guidance for STAAR’s medical affairs, professional affairs, and product development pathways. As well, Barnes will lead the company’s surgeon training, certification programs, and surgeon working groups, STAAR said.

Since 2012, Barnes has served as chief of ophthalmology services at Womack Army Medical Center in Fort Bragg, North Carolina.

Barnes has personally implanted more than 3,000 implantantable contact lenses in the eyes of soldiers, STAAR said.

He joined Womack in 2004 as chief of ophthalmology and refractive surgery and served as a theater ophthalmology consultant in Iraq and Afghanistan during 2005. In 2006, he returned to Womack as chief of refractive surgery, and, in 2008, he was designated Army Surgeon General A, which is similar to the professor level in a civilian institution.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

US Health Secretary Alex Azar Takes Aim at Rebates in US Senate Hearing

Beyeonics Surgical Raises $11.5 Million in Initial Funding Round

MeiraGTx Raises $75 Million in Initial Public Offering

GenSight to Pursue Approval for LHON Gene Therapy Candidate, Despite Phase III Setback

Optovue Receives FDA Clearance for AngioAnalytics, First OCT Angiography Metrics

Nexy Robotic Retinal Imaging System Receives FDA Clearance

Ocutrx Receives US Patent for Oculenz AR Glasses for Macular Degeneration

Allergan’s Bimatoprost SR Demonstrates Noninferiority to Timolol in Phase III Glaucoma Study

KKR to acquire Envision Healthcare, Including Amsurg ASC Business

Ophthalmologist Carmen Puliafito, MD, Seeks to Regain Medical License

Avedro Gains J Code for Photrexa Formulations in Preliminary CMS Decision

EyeGate Seeks to Study Ocular Bandage Gel in Punctate Epitheliopathy

Nicox, Ironwood to Collaborate on Novel Ophthalmic Treatments

US FDA Approves MDGH’s Moxidectin for Treatment of River Blindness

Bausch + Lomb Enrolls First Patient in Trial for enVista MX60EF Trifocal IOL

Cincinnati Eye Institute Partners with Private Equity Firm to Pursue National Expansion

Ophthotech Enters Gene Therapy Deals with University of Florida, University of Pennsylvania

Teva’s Launches Generic Version of Restasis in Canada

Clearside’s Phase II Trial for DME Candidate Meets Primary Endpoint

Orasis Raises $13 Million in Series B Financing

Coming soon

2018 Optical Coherence Tomography Report: A Global Market Analysis for 2017 to 2023